Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Hepion Pharmaceuticals (HEPA) has a market cap of $3.841 million USD. According to our data, Hepion Pharmaceuticals is ranked No.9064 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $3.84 M |
-23.04%
|
| Dec 31, 2024 | $4.99 M |
-85.49%
|
| Dec 29, 2023 | $34.41 M |
-46.00%
|
| Dec 30, 2022 | $63.72 M |
-73.68%
|
| Dec 31, 2021 | $0.24 B |
-47.95%
|
| Dec 31, 2020 | $0.47 B |
-59.14%
|
| Dec 31, 2019 | $1.14 B |
-72.85%
|
| Dec 31, 2018 | $4.19 B |
-90.21%
|
| Dec 29, 2017 | $42.82 B |
-70.00%
|
| Dec 30, 2016 | $142.73 B |
-22.08%
|
| Dec 31, 2015 | $183.17 B |
-30.63%
|
| Dec 31, 2014 | $264.04 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Madrigal Pharmaceuticals
MDGL
|
$6.77 B |
-0.324 B
|
USA
|
 Viking Therapeutics
VKTX
|
$2.55 B |
-0.042 B
|
USA
|
 Galmed Pharmaceuticals
GLMD
|
$3.18 M |
0.000 M
|
Israel
|
 Akero Therapeutics
AKRO
|
$2.97 B |
-0.066 B
|
USA
|
 Seabridge Gold
SA
|
$1.31 B |
61.134 M
|
Canada
|
 89bio
ETNB
|
$0.84 B |
-0.045 B
|
USA
|
 Terns Pharmaceuticals
TERN
|
$0.19 B |
-0.015 B
|
USA
|
 Enanta Pharmaceuticals
ENTA
|
$0.10 B |
-6.613 M
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
| Market Cap | = | HEPA Stock Price | * | HEPA Shares Outstanding |
| = | $0.35 | * | 1.08 M | |
| = | $3.84 M |